Insulin, insulin-like growth factors and colon cancer: A review of the evidence

Journal of Nutrition

Volumn 131, Issue 11 SUPPL., 2001, Pages

  Giovannucci, E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenomas; Colon cancer; Insulin; Insulin like growth factors

Indexed keywords

FATTY ACID; INSULIN; SOMATOMEDIN; STARCH;

APOPTOSIS; CALORIC RESTRICTION; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COLON CANCER; CONFERENCE PAPER; FAT INTAKE; HEREDITY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIFESTYLE; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY;

ANIMALIA;

EID: 0035160628     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.11.3109s     Document Type: Conference Paper

References (225)

1. The role of unsaturated bile acids in the etiology of large bowel cancer
2. Diet and excretion of bile acids
3. The effect of bile on the induction of experimental intestinal tumors in rats
4. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats
5. Dietary cholesterol, fat, and fibre, and colon-cancer mortality. An analysis of international data
6. Dietary fiber and the risk of colorectal cancer and adenoma in women
7. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas
8. Growth factors and cancer
9. Insulin-like growth factors and their binding proteins: Biological actions
10. Growth inhibition by insulin-like growth factor (IGF) binding protein-3-what's IGF got to do with it?
11. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53 and IGF-independent mechanism
12. Presence of somatomedin receptors on primary human breast and colon carcinomas
13. Characterization of insulin-like growth factor I receptors in human colon cancer
14. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line
15. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26
16. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29
17. Genetic alterations during colorectal-tumor development
18. Increased epithelial cell proliferation in the colon of patients with acromegaly
19. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma
20. The insulin-like growth factor 1 receptor: A key to tumor growth?
21. Insulin and IGF-I receptors in a human intestinal adenocarcinoma cell line (Caco-2) regulation of Na+ glucose transport across the brush border
22. Insulin-like growth factors and cancer
23. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells
24. Insulin-like growth factors and diabetes
25. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts
26. Insulin resistance - Mechanisms, syndromes, and implications
27. Hormonal and nutritional regulation of IGF-I and its binding proteins
28. Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children and adults
29. Insulin rapidly decreases insulin-like growth factor binding protein-1 gene transcription in streptozotocin-diabetic rats
30. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1
31. Clinical significance of IGF binding proteins
32. Clinical aspects of insulin-like growth factor binding proteins
33. Regulation and function of insulin-like growth factor-binding protein-1
34. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting
35. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: Control by nutritional variables
36. Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations
37. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes
38. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus
39. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
40. Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders
41. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs) and the IGF-binding proteins
42. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: Correlation with metabolic control and height attainment
43. Effect of obesity on total and free insulin-like growth factor (IGF)-I and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
44. Insulin stimulation of gene expression mediated by p21ras activation
45. Insulin and insulin-like growth factor-I signal transduction requires p21ras
46. The ras gene family and human carcinogenesis
47. Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis
48. Hyperinsulinemia potentiates activation of p21 Ras by growth factors
49. Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals
50. Dietary components that regulate serum somatomedin-C concentrations in humans
51. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients
52. Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment
53. Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: Alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor
54. Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction
55. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression
56. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
57. The growth hormone: Insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats
58. SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer
59. Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I
60. Insulin injections promote the growth of aberrant crypt foci in the colon of rats
61. Insulin promotion of colon tumors in rats
62. Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet
63. Aberrant crypt focus promotion and glucose intolerance: Correlation in the rat across diets differing in fat, n-3 fatty acids and energy
64. Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon
65. Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosurea
66. Colonic polyps in patients with acromegaly
67. Acromegaly and colon cancer
68. Gastrointestinal tumors in acromegalic patients
69. Acromegaly and colon cancer
70. Acromegaly and gastrointestinal adenocarcinomas
71. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer
72. High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age
73. Acromegaly, colonic polyps and carcinoma
74. Acromegaly and gastrointestinal cancer
75. Benign and malignant tumors in patients with acromegaly
76. Increased incidence of neoplasia in females with acromegaly
77. Increased prevalence of colonic adenomas in patients with acromegaly
78. Mortality and cancer incidence in acromegaly: A retrospective cohort study
79. Acromegaly and colon cancer
80. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3
81. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of coforectal neoplasia in women
82. High-risk colorectal adenomas and serum insulin-like growth factors
83. Serum C-peptide, insulin-like growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women
84. IGF-I and IGF-II in relation to colorectal cancer
85. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
86. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
87. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
88. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3
89. Nutritional regulation of the insulin-like growth factors
90. Epidemiology of insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study
91. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
92. Physical activity, obesity, and risk for colon cancer and adenoma in men
93. A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women
94. Adult stature and risk of cancer
95. Adult height and incidence of cancer in male physicians (United States)
96. Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: A case-control study among French Canadians in Montreal
97. Height, weight and gastrointestinal cancer: A follow-up study in Norway
98. Height, insulin-like growth factors and cancer risk
99. Leg length and risk of cancer in the Boyd Orr cohort
100. Body size and breast cancer risk among women under age 45 years
101. Conjugated estrogens and breast cancer risk
102. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women
103. Postmenopausal hormone use and risk of large-bowel cancer
104. Postmenopausal hormone use and risk for colorectal cancer and adenoma
105. Primary prevention of non-insulin-dependent diabetes mellitus
106. Pathogenesis of NIDDM. A balanced overview
107. Cancer and tuberculosis with some comments on cancer and other diseases
108. Carcinoma of the pancreas
109. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
110. Diabetes mellitus and cancer risk: A multisite case-control study
111. Colon carcinoma and diabetes mellitus
112. Cancer mortality among diabetics
113. Cancer risk in patients with diabetes mellitus
114. History of selected diseases and the risk of colorectal cancer
115. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
116. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan)
117. Colorectal cancer: Another complication of diabetes mellitus?
118. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
119. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis
120. Increased blood glucose and insulin, body size, and incident colorectal cancer
121. Insulin and colon cancer
122. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism
123. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man
124. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ
125. Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas
126. Serum lipids and adenomas of the left colon and rectum
127. The risk factor profile of recto-sigmoid adenomas: A prospective screening study of 665 patients in a clinical rehabilitation centre
128. Metabolic implications of body fat distribution
129. Relation of body fat distribution to metabolic complications of obesity
130. Impact of obesity on metabolism in men and women: Importance of regional adipose tissue distribution
131. Central obesity and coronary heart disease in men
132. Alcohol, physical activity and other risk factors for colorectal cancer: A prospective study
133. Physical activity and risk of developing colorectal cancer among college alumni
134. Variations in mortality by weight among 750,000 men and women
135. Height, weight and mortality. The Norwegian experience
136. Dietary relationships with fatal colorectal cancer among Seventh-Day Adventists
137. Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men
138. The relations of alcoholic beverage use to colon and rectal cancer
139. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935
140. Obesity in youth and middle age and risk of colorectal cancer in men
141. A prospective study of colon and rectal cancer among Hawaii Japanese men
142. Diet, physical activity and colorectal cancer among Chinese in North America and China
143. Body weight and physical activity as predictors of colorectal cancer risk
144. Dietary epidemiology of cancer of the colon in western New York
145. Dietary intake and colon cancer: Sex- and anatomic site-specific associations
146. The association of body size and large bowel cancer risk in Wisconsin (United States) women
147. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States)
148. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women
149. Physical activity, body size, and colorectal cancer in women
150. Body mass index and colon cancer in a national sample of adult US men and women
151. Energy balance and colon cancer - Beyond physical activity
152. Physical activity, obesity, and risk of colorectal adenoma in women (United States)
153. Obesity and colorectal adenomatous polyps
154. Obesity and adenomatous polyps of the sigmoid colon
155. Diet and risk of colorectal adenomas: Macronutrients, cholesterol and fiber
156. Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology
157. Obesity, weight gain and risk of colon adenomas in Japanese men
158. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum
159. Effects of diet- and exercise-induced weight loss on visceral adipose tissue in men and women
160. Physical training and insulin sensitivity
161. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study
162. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians
163. Daily physical activity, work capacity and glucose tolerance in lean and obese normoglycaemic middle-aged men
164. Effect of habitual physical activity on age-related glucose intolerance
165. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes
166. Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changes
167. How much physical activity is good for health?
168. An epidemiological perspective of the relationship between physical activity and NIDDM: From activity assessment to intervention
169. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization
170. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance
171. 13C nuclear magnetic resonance spectroscopy
172. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM)
173. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus
174. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women
175. A prospective study of exercise and incidence of diabetes among US male physicians
176. Risk factors for fatal colon cancer in a large prospective study
177. Physical activity and risk of large bowel cancer in the Framingham Study
178. Physical activity and risk of cancer in the NHANES I population
179. A prospective analysis of physical activity and cancer
180. Use of surveillance systems for occupational cancer: Data from the Danish national system
181. Physical activity and colon cancer risk
182. Physical activity and incidence of cancer in diverse populations: A preliminary report
183. Sedentary jobs and colon cancer
184. Effect of occupational and recreational activity on the risk of colorectal cancer among males: A case-control study
185. Physical activity, diet, and risk of colon cancer in Utah
186. A case-control study of occupational and dietary factors in colorectal cancer in young men by subsite
187. Occupational risk of colon cancer. An analysis of anatomic subsite
188. A population-based case-control study of colorectal cancer in Majorca. I. Dietary factors
189. A comparative case-control study of colorectal cancer and adenoma
190. A case-control study of male colorectal cancer in Aichi Prefecture, Japan: With special reference to occupational activity level, drinking habits and family history
191. Diet, body mass and colorectal cancer: A case-referent study in Stockholm
192. Colon cancer, physical activity, and occupational exposures. A case-control study
193. Occupational physical activity and risk of cancer of the colon and rectum in New Zealand males
194. A case-control study of physical activity in relation to risk of cancer of the right colon and rectum in men
195. Leisure-time physical activity, body size, and colon cancer in women
196. Physical activity and reduced risk of colon cancer: Implications for prevention
197. Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: A study of self-defense officials in Japan
198. Colorectal adenomas and energy intake, body size and physical activity: A case-control study of subjects participating in the Nottingham faecal occult blood screening programme
199. Leisure and occupational physical activity and risk of colorectal adenomatous polyps
200. Dietary carbohydrates and insulin sensitivity - A review of the evidence and clinical implications
201. Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance
202. Serum insulin and glucose in hyperinsulinemic subjects fed three different levels of sucrose
203. Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and gluccose response to a sucrose load
204. Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet
205. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men
206. Correlates of fasting insulin levels in young adults: The CARDIA study
207. Sucrose enhancement of the early steps of colon carcinogenesis in mice
208. Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon
209. Refined carbohydrate enhancement of aberrant crypt foci (ACF) in rat colon induced by the food-borne carcinogen 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)
210. Dietary sucrose and starch affect dysplastic characteristics in carcinogen-induced aberrant crypt foci in rat colon
211. Dietary sucrose, glucose, fructose, and starches affect colonic functions in rats
212. Eating frequency - A neglected risk factor for colon cancer?
213. Food groups and risk of colorectal cancer in Italy
214. Italian study on colorectal cancer with emphasis on influence of cereals
215. Dietary sugar and colon cancer
216. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients
217. A dietary trial with a short-term low-sucrose diet in an Italian population: Effects on colorectal mucosal proliferation
218. Environmental factors of cancer of the colon and rectum. II. Japanese epidemiological data
219. Food-group consumption and colon cancer in the Adelaide Case-Control Study. I. Vegetables and fruit
220. Diet and colorectal cancer: Results of two case-control studies in Russia
221. Prediction of glycemic index for starchy foods
222. Factor analysis of digestive cancer mortality and food consumption in 65 Chinese counties
223. The glycemic index: Methodology and clinical implications
224. Eating patterns and risk of colon cancer
225. The association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk